These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 9989767

  • 1. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
    Leung JC, Poon PY, Lai KN.
    J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
    [Abstract] [Full Text] [Related]

  • 2. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
    Leung JC, Tang SC, Chan DT, Lui SL, Lai KN.
    J Clin Lab Anal; 2002 Feb; 16(1):11-9. PubMed ID: 11835525
    [Abstract] [Full Text] [Related]

  • 3. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
    Lai KN, To WY, Li PK, Leung JC.
    Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
    [Abstract] [Full Text] [Related]

  • 4. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.
    Leung JC, Tang SC, Lam MF, Chan TM, Lai KN.
    Kidney Int; 2001 Jan; 59(1):277-85. PubMed ID: 11135081
    [Abstract] [Full Text] [Related]

  • 5. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
    Leung JC, Chan LY, Tang SC, Tam PC, Fenn J, Lai KN.
    Nephron Exp Nephrol; 2007 Jan; 107(3):e107-18. PubMed ID: 17957128
    [Abstract] [Full Text] [Related]

  • 6. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 7. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 8. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 9. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I, Gejyo F.
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [Abstract] [Full Text] [Related]

  • 10. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
    Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J.
    PLoS One; 2014 Oct; 9(2):e99026. PubMed ID: 24918438
    [Abstract] [Full Text] [Related]

  • 11. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX, Zhao MH.
    Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
    [Abstract] [Full Text] [Related]

  • 12. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Jul; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 13. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 14. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.
    Allen AC, Harper SJ, Feehally J.
    Clin Exp Immunol; 1995 Jun; 100(3):470-4. PubMed ID: 7774058
    [Abstract] [Full Text] [Related]

  • 15. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 16. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
    Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):268-74. PubMed ID: 10777713
    [Abstract] [Full Text] [Related]

  • 17. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun 29; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 18. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
    Stuchlova Horynova M, Vrablikova A, Stewart TJ, Takahashi K, Czernekova L, Yamada K, Suzuki H, Julian BA, Renfrow MB, Novak J, Raska M.
    Nephrol Dial Transplant; 2015 Feb 29; 30(2):234-8. PubMed ID: 25281698
    [Abstract] [Full Text] [Related]

  • 19. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec 29; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 20. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
    Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J.
    J Am Soc Nephrol; 1999 Aug 29; 10(8):1763-71. PubMed ID: 10446944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.